Pfizer to close over 50-yr old plant at Thane

Image
Press Trust of India New Delhi
Last Updated : Jul 15 2015 | 6:02 PM IST
Drug firm Pfizer today said it is closing its over 50-year old Thane plant, which was lying idle since 2013, from September 16, 2015.
"The decision to close the site is based on an assessment of its long-term viability and its ability to achieve the needed production. There has practically been no production activity at this plant since 2013...," a Pfizer spokesperson said.
The spokesperson added that the closure of the facility will not impact supply of any of the company's medicines to patients.
The plant, which employed 212 workers, had offered a voluntary retirement scheme (VRS) last year. This was taken up by as many as 132 workmen, the spokesperson said.
"The remaining 80 workmen have continued to receive full wages, despite plant inactivity. As a part of the closure process, the company will honour its obligations towards requisite compensation, as mandated by law, for the remaining workmen," the company spokesperson said.
In a filing to the BSE, Pfizer said, "the company has intimated the concerned authorities that it intends to effect closure of its plant situated at Thane Belapur Road,... Navi Mumbai with effect from September 16, 2015".
The Thane plant was commissioned in the 1960s. It had produced a number of medicines for both domestic and international markets.
Shares of Pfizer today closed at Rs 2,105.20 per scrip on BSE, down 0.26 per cent from previous close.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 15 2015 | 6:02 PM IST

Next Story